Clincosm LogoSign in Get a demo

Pulmonary Arterial Hypertension

Showing 26 - 50 of 429
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Arterial Hypertension Trial in Worldwide (Sotatercept, Placebo)

Recruiting
  • Pulmonary Arterial Hypertension
  • Phoenix, Arizona
  • +137 more
Jan 27, 2023

Pulmonary Vascular Disease Phenomics Program PVDOMICS

Active, not recruiting
  • Pulmonary Arterial Hypertension
  • No Intervention
  • Tucson, Arizona
  • +6 more
Jan 27, 2023

Pulmonary Arterial Hypertension Trial in Heidelberg, Lodz, Wroclaw (LTP001, Placebo)

Recruiting
  • Pulmonary Arterial Hypertension
  • Caba, Buenos Aires, Argentina
  • +8 more
Jan 23, 2023

Pulmonary Arterial Hypertension Trial in Ann Arbor (Usual Care, Home-based exercise program)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • Usual Care
  • Home-based exercise program
  • Ann Arbor, Michigan
    The University of Michigan
Jan 23, 2023

Learn About How Well Riociguat Works, How Safe it is and How it

Recruiting
  • Pulmonary Arterial Hypertension
  • Riociguat (Adempas, BAY63-2521)
  • Phoenix, Arizona
  • +49 more
Jan 20, 2023

Pulmonary Arterial Hypertension, Hypertension, Pulmonary Trial in Worldwide (MK-5475, Placebo to MK-5475)

Recruiting
  • Pulmonary Arterial Hypertension
  • Hypertension, Pulmonary
  • Sacramento, California
  • +82 more
Jan 19, 2023

Pulmonary Arterial Hypertension Trial in Worldwide (GB002 (seralutinib), Generic Dry Powder Inhaler)

Recruiting
  • Pulmonary Arterial Hypertension
  • GB002 (seralutinib)
  • Generic Dry Powder Inhaler
  • Los Angeles, California
  • +28 more
Jan 13, 2023

Pulmonary Arterial Hypertension Trial in Japan (Satralizumab (Genetical Recombination))

Recruiting
  • Pulmonary Arterial Hypertension
  • Satralizumab (Genetical Recombination)
  • Chiba, Japan
  • +8 more
Jan 10, 2023

Pulmonary Arterial Hypertension Trial in Worldwide (Placebo, Sotatercept)

Completed
  • Pulmonary Arterial Hypertension
  • Phoenix, Arizona
  • +42 more
Jan 11, 2023

Pulmonary Arterial Hypertension, Interstitial Lung Disease, Healthy Adults Trial in Rochester (Treprostinil, Right Heart

Recruiting
  • Pulmonary Arterial Hypertension
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 9, 2023

Next Generation Infusion Pumps to Administer Remodulin

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • Remunity Pump for Remodulin
  • (no location specified)
Dec 29, 2022

Pulmonary Arterial Hypertension, Connective Tissue Diseases Trial in Mexico City

Recruiting
  • Pulmonary Arterial Hypertension
  • Connective Tissue Diseases
    • Mexico City, Mexico
      Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
    Dec 19, 2022

    Pulmonary Arterial Hypertension, Cardiovascular Diseases, Respiratory Disease Nursing Trial in São Paulo (Aerobic and Resistance

    Not yet recruiting
    • Pulmonary Arterial Hypertension
    • +4 more
    • Aerobic and Resistance training with rehabilitation
    • Health education
    • São Paulo, Sao Paulo, Brazil
      Luciana Maria Malosa Sampaio
    Dec 16, 2022

    Pulmonary Arterial Hypertension Trial (MN-08 24 mg/day, MN-08 60 mg/day)

    Not yet recruiting
    • Pulmonary Arterial Hypertension
    • MN-08 24 mg/day
    • MN-08 60 mg/day
    • (no location specified)
    Dec 14, 2022

    Non-invasive Pulmonary Artery Prediction (ADOPTS)

    Not yet recruiting
    • Heart Failure
    • Pulmonary Arterial Hypertension
    • right heart catheterization
    • Loma Linda, California
      Loma Linda Veterans Administration Healthcare System
    Dec 9, 2022

    Pulmonary Arterial Hypertension Trial (Treprostinil Palmitil, Placebo)

    Not yet recruiting
    • Pulmonary Arterial Hypertension
    • Treprostinil Palmitil
    • Placebo
    • (no location specified)
    Dec 6, 2022

    Pulmonary Arterial Hypertension Trial in Indianapolis (AV-101)

    Recruiting
    • Pulmonary Arterial Hypertension
    • Indianapolis, Indiana
      Indiana University Health
    Dec 6, 2022

    Pulmonary Arterial Hypertension Trial in Gothenburg (CS1 Administration)

    Recruiting
    • Pulmonary Arterial Hypertension
    • CS1 Administration
    • Gothenburg, Sweden
      Niklas Bergh
    Dec 5, 2022

    Pulmonary Arterial Hypertension Trial (cardiac magnetic resonance imaging)

    Not yet recruiting
    • Pulmonary Arterial Hypertension
    • cardiac magnetic resonance imaging
    • (no location specified)
    Nov 14, 2022

    Non-invasive Pulmonary Artery Prediction

    Recruiting
    • Heart Failure
    • Pulmonary Arterial Hypertension
    • catheterization
    • Los Angeles, California
      PIH Good Samaritan Hospital
    Nov 9, 2022

    Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Los Angeles (Non-invasive hemodynamic

    Enrolling by invitation
    • Pulmonary Arterial Hypertension
    • Chronic Thromboembolic Pulmonary Hypertension
    • Non-invasive hemodynamic measurements
    • Los Angeles, California
      Ronald Reagan UCLA Medical Center
    Nov 8, 2022

    Pulmonary Arterial Hypertension Trial in Spain (No intervention - Observational study)

    Recruiting
    • Pulmonary Arterial Hypertension
    • No intervention - Observational study
    • El Ejido, Almería, Spain
    • +9 more
    Nov 2, 2022

    Pulmonary Arterial Hypertension Trial in United States (Treprostinil Inhalation Powder)

    Active, not recruiting
    • Pulmonary Arterial Hypertension
    • Treprostinil Inhalation Powder
    • Birmingham, Alabama
    • +18 more
    Nov 2, 2022

    Pulmonary Arterial Hypertension, Right Ventricular Dysfunction Trial in Shanghai (passive leg raising, dobutamine test, inhaled

    Recruiting
    • Pulmonary Arterial Hypertension
    • Right Ventricular Dysfunction
    • passive leg raising
    • +2 more
    • Shanghai, Shanghai, China
      Zhongshan hospital Fudan University
    Oct 19, 2022

    Pulmonary Arterial Hypertension, Randomized Controlled Trial Trial in Beijing (Tolvaptan, Furosemide)

    Recruiting
    • Pulmonary Arterial Hypertension
    • Randomized Controlled Trial
    • Beijing, China
      center of pulmonary vascular disease, Fuwai hospital
    Oct 4, 2022